key: cord-0956293-cek9gxbx authors: Mira‐Iglesias, Ainara; Mengual‐Chuliá, Beatriz; Cano, Laura; García‐Rubio, Javier; Tortajada‐Girbés, Miguel; Carballido‐Fernández, Mario; Mollar‐Maseres, Juan; Schwarz‐Chavarri, Germán; García‐Esteban, Sandra; Puig‐Barberà, Joan; Díez‐Domingo, Javier; López‐Labrador, F. Xavier title: Retrospective screening for SARS‐CoV‐2 among influenza‐like illness hospitalizations: 2018–2019 and 2019–2020 seasons, Valencia region, Spain date: 2021-09-16 journal: Influenza Other Respir Viruses DOI: 10.1111/irv.12899 sha: 25484b0c2892842e81bc5e3dcdb4fdaf90370573 doc_id: 956293 cord_uid: cek9gxbx On 9 March 2020, the World Health Organization (WHO) Global Influenza Programme (GIP) asked participant sites on the Global Influenza Hospital Surveillance Network (GIHSN) to contribute to data collection concerning severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). We re‐analysed 5833 viral RNA archived samples collected prospectively from hospital admissions for influenza‐like illness (ILI) in the Valencia Region of Spain by the Valencia Hospital Surveillance Network for the Study of Influenza and Other Respiratory Viruses (VAHNSI) network (four hospitals, catchment area population 1 118 732) during the pre‐pandemic 2018/2019 (n = 4010) and pandemic 2019/2020 (n = 1823) influenza seasons for the presence of SARS‐CoV‐2. We did not find evidence for community‐acquired SARS‐CoV‐2 infection in hospital admissions for ILI in our region before early March 2020. The first case of coronavirus disease 2019 (COVID- 19) due to severe acute respiratory syndrome coronavirus (SARS-CoV-2) was detected in Wuhan (Hubei province, China) at the end of 2019, and the virus rapidly spread to other Chinese provinces and countries. 1 As of 3 June 2020, the World Health Organization (WHO) had already reported the presence of SARS-CoV-2 in 54 different European countries. 2 In Spain, the first imported and locally acquired COVID-19 cases were detected on 31 January and 26 February 2020, respectively. 3, 4 Since then, until beginning of June, Spain accounted for 240 660 confirmed cases and 27 133 deaths. Among total registered deaths, 86% were in people aged 70 or older, and 95% had previous underlying chronic conditions. 5 Symptomatology described by SARS-CoV-2-infected patients was almost identical to the common influenza-like illness (ILI) symptoms, 6, 7 and COVID-19 cases may have occurred in Spain earlier than previously recognized. 8 Prevention and Control (ECDC) ILI case definition, 9 defined as the presence of, at least, one systemic symptom (fever or feverishness, malaise, myalgia or headache) and, at least, one respiratory symptom (shortness of breath, sore throat or cough), with an onset of symptoms in the 7 days prior to admission. For children less than 5 years old, we only require an onset of one symptom (Table S1 ) in the 7 days prior to admission. Finally, patients need to be in hospital between 8 and 48 h to be enrolled and swabbed (combined nasopharyngeal and oropharyngeal in universal transport medium), after written informed consent. Clinical and demographic characteristics from patients were obtained by a face-to-face interview or by consulting medical records. To our knowledge, our study is the first comprehensive screening for SARS-CoV-2 in ILI cases at the population level in the pre-pandemic period in Europe. We describe here the first SARS-CoV-2 admission in the Valencia Region without travel history and thus likely due to community transmission in early March 2020. The infected patient was an old diabetic man in his late 70s who was also developing a neoplasia. It is widely known that COVID-19 mainly affects elderly people 12,13 as well as people with underlying chronic conditions 14 The first SARS-CoV-2 cases in hospital admissions in Europe had been identified at the end of January or early February 2020 as related to travel to, or to contacts with, travellers from China. [26] [27] [28] Later, retrospective analysis identified earlier cases from early or late The authors declare the following financial interests/personal relationships that may be considered as potential competing interests: FXL, F I G U R E 2 Number of detections for 19 respiratory viruses in the VAHNSI network during the 2019/2020 influenza season by epidemiological week (1 November 2019 to 14 March 2020). The timing for the first ILI admission positive for SARS-CoV-2 is indicated BMC, AMI and JDD report funding from Sanofi Pasteur, other than corresponding to the study. Data collection was partially supported by a grant from the Foundation for Influenza Epidemiology (FIE), which supports the Global Influenza Hospital Surveillance Network (see www.gihsn.org for more details). The sponsor did not participate in the study design, data analysis and interpretation, in the writing of the manuscript or in the decision to submit the manuscript for publishing. The peer review history for this article is available at https://publons. com/publon/10.1111/irv.12899. De-identified data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. Ainara Mira-Iglesias https://orcid.org/0000-0001-6371-8229 Situation report-1. World Health Organization Situation report-135. World Health Organization Primeros casos investigados en España por Covid-2019. Informe Covid-2019 no 1 Madrid: ISCIII; 2020 Informe sobre los casos de COVID-19 confirmados en España Informe COVID-19 no 3 Enfermedad por el coronavirus (COVID-19) 04.06.2020. Ministerio de Sanidad. Gobierno de España Clinical features of patients infected with 2019 novel coronavirus in Wuhan Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up Excess cases of influenza suggest an earlier start to the coronavirus epidemic in Spain than official figures tell us: an analysis of primary care electronic medical records from over 6 million people from Catalonia Commission implementing decision of 8 August 2012 amending decision 2002/253/EC laying down case definitions for reporting communicable diseases to the community network under decision No. 2119/98/EC of the European Parliament and of the Council Publications Office of the European Union Molecular assays to diagnose COVID-19: summary table of available protocols Metagenomic sequencing with spiked primer enrichment for viral diagnostics and genomic surveillance Clinical characteristics of coronavirus disease 2019 in China Clinical features of COVID-19 in elderly patients: a comparison with young and middle-aged patients Comorbid chronic diseases are strongly correlated with disease severity among COVID-19 patients: a systematic review and meta-analysis Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 infection Analysis of clinical features and outcomes of 161 patients with severe and critical COVID-19: a multicenter descriptive study Autopsy findings from the first known death from severe acute respiratory syndrome SARS-CoV-2 in Spain Working group for the surveillance and control of COVID-19 in Spain. The first wave of the COVID-19 pandemic in Spain: characterisation of cases and risk factors for severe outcomes SARS-CoV-2 detection in patients with influenza-like illness A founder effect led early SARS-CoV-2 transmission in Spain Retrospective search of SARS-CoV-2 in respiratory samples in Vallès Occidental No evidence of SARS-CoV-2 circulation in Rome (Italy) during the pre-pandemic period: results of a retrospective surveillance Retrospective screening for SARS-CoV-2 RNA in California Epidemiology of severe acute respiratory syndrome coronavirus 2 emergence amidst communityacquired respiratory viruses Interactions between SARS-CoV-2 and Influenza and the impact of coinfection on disease severity: a test negative design Early introduction of severe acute respiratory syndrome coronavirus 2 into Europe Clinical and virological data of the first cases of COVID-19 in Europe: a case series First cases of coronavirus disease 2019 (COVID-19) in the WHO European region Evidence of SARS-CoV-2 RNA in an oropharyngeal swab specimen SARS-CoV-2 was already spreading in France in late Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy Sample pooling as a strategy to detect community transmission of SARS-CoV-2 Retrospective screening for SARS-CoV-2 among influenza-like illness hospitalizations